PBH EV/EBITDA: current value, 10-year range and year-by-year history
Cash & Leverage
PBH's ev/ebitda is right around its 10-year median of 13.9.
EV/EBITDA History
PBH EV/EBITDA by year
Yearly range of PBH’s ev/ebitda from 2016 to 2026. Over the full period it ranged from 9.5 to 647.1, averaging 62.9.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 9.5 | 12.1 | 14.7 | 13.5 |
| 2025 | 10.5 | 12.9 | 15.2 | 11.8 |
| 2024 | 11.4 | 111.1 | 456.9 | 13.6 |
| 2023 | 11.7 | 385.0 | 647.1 | 385.4 |
| 2022 | 10.8 | 12.3 | 13.8 | 12.6 |
| 2021 | 10.2 | 12.5 | 14.5 | 13.6 |
| 2020 | 9.7 | 18.2 | 45.3 | 10.0 |
| 2019 | 14.2 | 31.5 | 42.2 | 42.2 |
| 2018 | 11.7 | 15.1 | 17.2 | 15.2 |
| 2017 | 13.8 | 17.9 | 22.8 | 14.5 |
| 2016 | 17.6 | 18.4 | 19.4 | 19.3 |
Get notified when PBH EV/EBITDA crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
An acquisition-style valuation multiple: Enterprise Value (market cap + net debt) divided by operating earnings before accounting adjustments. Compares companies fairly regardless of their capital structure.
(Market Cap + Net Debt) / EBITDAUnlike P/E, this metric accounts for debt — two companies with identical operations but different leverage will show similar EV/EBITDA. Low vs history suggests the total business is modestly priced.
- EBITDA ignores capital expenditure. For asset-heavy businesses (airlines, mining, utilities), this understates the real cost — use EV/EBIT or EV/FCF instead.
- Large acquisitions temporarily spike net debt and can distort the ratio for 1–2 years during integration.
Is PBH EV/EBITDA High or Low Right Now?
Prestige Consumer Healthcare Inc.'s EV/EBITDA is currently 13.5, which is around average relative to its 10-year historical range. The 10-year median EV/EBITDA for PBH is approximately 13.9. See all PBH valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.